Mark McGowan has been named interim president and CEO of CombiMatrix, effective July 1. McGowan, who is also chairman of CombiMatrix's board of directors, will replace outgoing President and CEO Amit Kumar, who has led the firm for the past decade.
CombiMatrix said that it recently retained Caldwell Partners to lead the search and recruitment of a permanent president and CEO.
Myriad Genetics has elected Heiner Dreismann to serve on its board of directors. Dreismann spent two decades at Roche and served as president and CEO of Roche Molecular Systems, and he currently serves on the boards of several healthcare companies.
Response Genetics has named Michael McNulty as its new chief operating officer. McNulty joins the firm from Agilent Technologies, where he most recently served as general manager of diagnostics. He also previously served as vice president of laboratory operations at Berkeley HeartLab.